CEO Karen Wurster, Adipo Therapeutics (IMAGE) Purdue University Caption Adipo Therapeutics CEO Karen Wurster. Adipo Therapeutics has successfully raised $1.9 million in bridge funds that will be used to complete critical studies to demonstrate its lead asset can convert energy-storing white adipose tissue to energy-burning brown adipose tissue in human fat. Credit (The ESC Plan photo/Charles Jischke) Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.